Fischbach Wolfgang, Goebeler-Kolve Mariele, Starostik Petr, Greiner Axel, Müller-Hermelink Hans Konrad
Department of Internal Medicine II, Klinikum Aschaffenburg, 63739 Aschaffenburg, Germany.
Lancet. 2002 Aug 17;360(9332):547-8. doi: 10.1016/S0140-6736(02)09711-8.
Helicobacter pylori eradication is the initial treatment of choice in localised low-grade gastric MALT (mucosa-associated lymphoid-tissue)-type lymphoma. We describe the natural course of seven patients who refused further oncological treatment for persistent lymphoma after successful eradication of H pylori. Despite persistent clonality, neither lymphoma progression nor high-grade transformation arose during a mean observation period of 34 (range 22-44) months. In view of the favourable course of these patients, a watch-and-wait strategy could be a valid approach to management of this disease.
幽门螺杆菌根除是局限性低度胃黏膜相关淋巴组织(MALT)型淋巴瘤的首选初始治疗方法。我们描述了7例患者的自然病程,这些患者在成功根除幽门螺杆菌后,因持续性淋巴瘤而拒绝进一步的肿瘤治疗。尽管克隆性持续存在,但在平均34个月(范围22 - 44个月)的观察期内,既没有出现淋巴瘤进展,也没有发生高级别转化。鉴于这些患者的良好病程,观察等待策略可能是管理这种疾病的有效方法。